AL
ANGO icon

Airain Ltd’s AngioDynamics ANGO Stock Holding History

Airain Ltd’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$320K Buy
+19,746
New +$312K 0.01% 644
2015
Q4 		– Sell
-15,358
Closed -$203K – 818
2015
Q3 		$203K Buy
+15,358
New +$232K 0.01% 705

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

Airain Ltd's ANGO Position: Q2 2017 in Review

Airain Ltd opened a new position in AngioDynamics (ANGO) in Q2 2017: 19,746 shares worth $320K. The stake represents 0.01% of the portfolio and ranks #644 among its holdings. This is a return to the name: Airain Ltd previously reported a position in ANGO as recently as Q3 2015.

Airain Ltd first reported a position in ANGO in Q3 2015 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2017.

  • Airain Ltd held 19,746 shares of AngioDynamics worth $320K as of Q2 2017.
  • AngioDynamics was a new Airain Ltd position in Q2 2017.
  • AngioDynamics made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #644 holding.
  • Airain Ltd first reported a position in AngioDynamics in Q3 2015 and has held it in 2 quarters since.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.